MEMS  

 
  MEMS  
About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » CME » 
President’s Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
CME
Endocrine Modules
Endocrine Update
Combined Clinical Meeting
CPG
In the Press
Disease Areas
Healthy Lifestyle
Publications
Research Programs
Awards
Photo & Video Gallery
Useful Links
Disease Management
Home
 
arrow Endocrine Update 2016
15-11-2016
Section: CME
Theme: Pearls in Practical Endocrinology
Date: 22nd October 2016
Venue: Dewan Batu Bersurat, Muzium Negeri Terengganu
»Read more...
 


arrow MEMS Endo Update in KT
31-10-2016
Section: CME
MEMS's Endo Updates in KT was held on 22 October 2016.
Theme: Pearls in Practical Endocrinology
»Read more...
 


arrow Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes - NEJM
21-12-2015
The SGLT2 inhibitor, empagliflozin, significantly reduced deaths among individuals with type 2 diabetes and established cardiovascular disease (CVD) when compared with placebo in what is being heralded as a landmark trial.
»Read more...
 


arrow Menopausal hormone therapy association with breast cancer strengthened
29-10-2010
In 2002, the Women's Health Initiative (WHI) randomized trial of placebo vs hormone therapy with estrogen and progestin was stopped early because of evidence of harm.1 Sales of combined estrogen-progestin plummeted 32% between the period immediately before the study's release and the analogous period 1 year later, as the WHI trial had shown that hormone therapy increased a woman's risk of breast cancer and myocardial infarction.
»Read more...
 


arrow New propylthiouracil warnings change face of hyperthyroid treatment in pregnancy
17-09-2010
Untreated hyperthyroidism in pregnancy places the mother and child at an elevated risk for a number of adverse outcomes, including preeclampsia and congestive heart failure. Because radioactive iodine is not a viable option during pregnancy, and surgery is risky, health care professionals are limited to propylthiouracil and methimazole.
»Read more...
 


arrow Sodium Glucose Transporter-2 (SGLT-2) Inhibitors: A New Class of Anti-Diabetic Agent
4-08-2010
Aretaus, one of the most celebrated of the ancient Greek physicians coined the term "diabetes" when he derived the name for the wasting disease from the Greek word “siphon" (diabaino in Ionian Greek, meaning “passing through”). While the 17th century London physician, Dr Thomas Willis, diagnosed "honeyed" diabetes by sampling the urine of his patients.
»Read more...
 


 
   
 



 
 
| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition